Literature DB >> 26759497

Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.

Marisa Holubar1, Stephanie B Troy2, Kusum Nathoo3, Lynda Stranix-Chibanda3,4, Georgina Musingwini4, Nivedita Srinivas1, ChunHong Huang1, Alexandra Junn5, Meira S Halpern1, Yvonne A Maldonado1,4.   

Abstract

Community circulation of oral poliovirus vaccine (OPV) likely begins with household transmission. We analyzed stool collected from Zimbabwean mothers who were infected with human immunodeficiency virus (HIV) and those who were uninfected with HIV 1 to 24 weeks after infant oral poliovirus vaccination. Overall, only 5% of the mothers had detectable OPV (16 of 304) despite high infant shedding rates. OPV shedding was similar between HIV-infected mothers and those who were uninfected (11 [6.4%] of 171 vs 5 [3.8%] of 133, respectively) and between mothers of HIV-infected infants and those of uninfected infants (2 [3.5%] of 57 vs 9 [6.3%] of 144, respectively). Mothers of vaccinated infants are unlikely to shed OPV, even when they are infected with HIV. © Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  OPV; OPV shedding; contact shedding of OPV; oral poliovirus vaccine; poliovirus transmission

Mesh:

Substances:

Year:  2017        PMID: 26759497      PMCID: PMC5907849          DOI: 10.1093/jpids/piv083

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  11 in total

Review 1.  Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.

Authors:  P E Fine; I A Carneiro
Journal:  Am J Epidemiol       Date:  1999-11-15       Impact factor: 4.897

Review 2.  Mucosal immunity in human and simian immunodeficiency lentivirus infections.

Authors:  J M Brenchley
Journal:  Mucosal Immunol       Date:  2013-04-03       Impact factor: 7.313

3.  Real-time Polymerase Chain Reaction Analysis of Sewage Samples to Determine Oral Polio Vaccine Circulation Duration and Mutation After Mexican National Immunization Weeks.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Sergio Canizales-Quintero; ChunHong Huang; Yu-Jin Lee; Renata Báez-Saldaña; Elizabeth Ferreira-Guerrero; Lourdes García-García; Yvonne Maldonado
Journal:  J Pediatric Infect Dis Soc       Date:  2012-06-29       Impact factor: 3.164

4.  Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer.

Authors:  Edwin J Asturias; Carlos F Grazioso; Sandra Luna-Fineman; Olga Torres; Neal A Halsey
Journal:  Biologicals       Date:  2006-05-08       Impact factor: 1.856

5.  No evidence of prolonged enterovirus excretion in HIV-seropositive patients.

Authors:  Ionela Gouandjika-Vasilache; Chantal Akoua-Koffi; Evelyne Begaud; Annick Dosseh
Journal:  Trop Med Int Health       Date:  2005-08       Impact factor: 2.622

6.  Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.

Authors:  M Benyesh-Melnick; J L Melnick; W E Rawls; I Wimberly; J B Oro; E Ben-Porath; V Rennick
Journal:  Am J Epidemiol       Date:  1967-07       Impact factor: 4.897

7.  An oral poliovirus vaccine trial in Costa Rica.

Authors:  J R Paul; D M Horstmann; J T Riordan; E M Opton; J C Niederman; E P Isacson; R H Green
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

8.  Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.

Authors:  Stephanie B Troy; Georgina Musingwini; Meira S Halpern; Chunhong Huang; Lynda Stranix-Chibanda; Diana Kouiavskaia; Avinash K Shetty; Konstantin Chumakov; Kusum Nathoo; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-05-09       Impact factor: 5.226

9.  Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010-2011, informed by a pre-outbreak poliovirus immunity assessment.

Authors:  Mary M Alleman; Kathleen A Wannemuehler; William C Weldon; Jean Pierre Kabuayi; Felly Ekofo; Samuel Edidi; Audry Mulumba; Albert Mbule; Renée N Ntumbannji; Tiekoura Coulibaly; Nadine Abiola; Minlangu Mpingulu; Kassim Sidibe; M Steven Oberste
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

10.  Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.

Authors:  Ousmane M Diop; Cara C Burns; Steven G Wassilak; Olen M Kew
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586

View more
  4 in total

1.  Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau.

Authors:  Ane B Fisker; Justiniano S D Martins; Line M Nanque; Andreas M Jensen; Elsi J C Ca; Sebastian Nielsen; Cesario L Martins; Amabelia Rodrigues
Journal:  Open Forum Infect Dis       Date:  2022-09-11       Impact factor: 4.423

2.  Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.

Authors:  Jonathan Altamirano; Natasha Purington; Rasika Behl; Clea Sarnquist; Marisa Holubar; Lourdes García-García; Leticia Ferreyra-Reyes; Rogelio Montero-Campos; Luis Pablo Cruz-Hervert; Shanda Boyle; John Modlin; Christopher van Hoorebeke; Sean Leary; ChunHong Huang; Marvin Sommer; Elizabeth Ferreira-Guerrero; Guadalupe Delgado-Sanchez; Sergio Canizales-Quintero; José Luis Díaz Ortega; Manisha Desai; Yvonne A Maldonado
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

3.  Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.

Authors:  Meira S Halpern; Jonathan Altamirano; Yvonne Maldonado
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

4.  Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.

Authors:  Christopher I Jarvis; Jonathan Altamirano; Clea Sarnquist; W John Edmunds; Yvonne Maldonado
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.